Contineum Therapeutics, Inc.

CTNM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Oct 28, 2026
SCHEDULE 13G/A Oct 28, 2026
SCHEDULE 13G Oct 22, 2026
144 Oct 1, 2026
8-K Sep 14, 2026 8-K
4 Sep 8, 2026 FORM 4
144 Sep 8, 2026
144 Sep 1, 2026
SCHEDULE 13G/A Aug 14, 2026
4 Aug 3, 2026 FORM 4
144 Aug 3, 2026
144 Aug 3, 2026
10-Q Jul 30, 2026 10-Q
8-K Jul 30, 2026 8-K
SCHEDULE 13G Jul 27, 2026
SCHEDULE 13G/A Jul 17, 2026
8-K Jul 13, 2026 8-K
4 Jul 10, 2026 FORM 4
4 Jul 8, 2026 FORM 4
144 Jul 8, 2026
4 Jul 2, 2026 FORM 4
4 Jul 1, 2026 FORM 4
4 Jul 1, 2026 FORM 4
144 Jul 1, 2026
144 Jun 30, 2026
← Newer Page 1 of 8 · 197 filings Older →